As of April 16, 2025, Entrada Therapeutics (TRDA) has a market cap of $0.30 billion USD. According to our data, Entrada Therapeutics is ranked No.6523 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.30 B |
-54.27%
|
Dec 31, 2024 | $0.65 B |
14.58%
|
Dec 29, 2023 | $0.56 B |
11.61%
|
Dec 30, 2022 | $0.51 B |
-21.03%
|
Dec 31, 2021 | $0.64 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
![]() USA
|
![]() Wave Life Sciences
WVE
|
$0.96 B |
-0.000 M
|
![]() Singapore
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() PTC Therapeutics
PTCT
|
$3.70 B |
-0.000 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
Market Cap | = | TRDA Stock Price | * | TRDA Shares Outstanding |
= | $7.87 | * | 37.59 M | |
= | $0.30 B |